ZA200903242B - Treatment for multiple myeloma - Google Patents
Treatment for multiple myelomaInfo
- Publication number
- ZA200903242B ZA200903242B ZA200903242A ZA200903242A ZA200903242B ZA 200903242 B ZA200903242 B ZA 200903242B ZA 200903242 A ZA200903242 A ZA 200903242A ZA 200903242 A ZA200903242 A ZA 200903242A ZA 200903242 B ZA200903242 B ZA 200903242B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- multiple myeloma
- myeloma
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title 1
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86112006P | 2006-11-27 | 2006-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200903242B true ZA200903242B (en) | 2010-08-25 |
Family
ID=41284118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200903242A ZA200903242B (en) | 2006-11-27 | 2007-11-27 | Treatment for multiple myeloma |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101568342A (en) |
| ZA (1) | ZA200903242B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103709172B (en) * | 2012-09-28 | 2018-02-13 | 江苏先声药业有限公司 | Substituted furan and piperidine derivative and its application |
| JP2020528418A (en) * | 2017-07-26 | 2020-09-24 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | Combination therapy with BET inhibitors and Bcl-2 inhibitors |
-
2007
- 2007-11-27 CN CNA2007800478308A patent/CN101568342A/en active Pending
- 2007-11-27 ZA ZA200903242A patent/ZA200903242B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101568342A (en) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2079414A4 (en) | System for chemohyperthermia treatment | |
| AP2009004746A0 (en) | Process for prepaiIrng diaminophenothiazinium compounds | |
| SI2029155T1 (en) | Improved treatment of multiple myeloma | |
| GB0624874D0 (en) | Treatment | |
| GB0611210D0 (en) | Process | |
| GB0614823D0 (en) | Process | |
| GB0620793D0 (en) | Process | |
| GB0607394D0 (en) | Process | |
| GB0600914D0 (en) | Process | |
| EP2174956A4 (en) | Compositions for anti-fibrinolitic treatment | |
| GB0607395D0 (en) | Process | |
| GB0618235D0 (en) | Process | |
| GB0624807D0 (en) | Process | |
| GB0625190D0 (en) | Process | |
| PL2043792T3 (en) | System for continuous treatment | |
| GB0611741D0 (en) | Process | |
| GB0614485D0 (en) | Process | |
| GB0604874D0 (en) | Process | |
| IL205752A0 (en) | Octahydroquinolizines for antidiabetic treatment | |
| ZA200903242B (en) | Treatment for multiple myeloma | |
| GB0607952D0 (en) | Novel treatment | |
| GB0614613D0 (en) | Process | |
| GB0604233D0 (en) | Process | |
| GB0604460D0 (en) | Treatment | |
| GB0613676D0 (en) | Process |